title: Percutaneous Intraluminal Radiofrequency Ablation for Malignant Extrahepatic Biliary Obstruction: A Safe and Feasible Method.
abstract: BACKGROUND
  The Habib™ EndoHBP catheter is a novel bipolar radiofrequency catheter developed for intraluminal ablation to relieve malignant extrahepatic biliary obstruction. Clinical experience with its use is limited and scattered.
  
  
  OBJECTIVE
  The purpose of this study was to evaluate the clinical feasibility and safety of this technique.
  
  
  METHODS
  A single central retrospective analysis was performed with patients who underwent percutaneous intraluminal radiofrequency ablation (RFA) combined with biliary stenting for treatment of extrahepatic obstructive jaundice between September 2011 and May 2014. A Habib™ EndoHBP catheter was used for RFA. Clinical and telephonic follow-ups were carried out. Procedure-related complications, stent patency, patient survival rate and postoperative biochemical tests were investigated.
  
  
  RESULTS
  All the 47 patients tolerated well a total of 65 RFA procedures with self-expandable metal stents placed. The predominant disease was distal cholangiocarcinoma (16 of 47 cases). No procedure-related hemobilia or infections occurred. The main postablation complication was pain which could be controlled by analgesics. One patient suffered abdominal hemorrhage, diagnosed by blood test and abdominal ultrasonography and cured with conservative therapy. Significantly decreased TBIL and DBIL levels (P < 0.05) were observed on day 7 postoperatively. Stent patency was 149 days (15-281). Median survival was 181 days (15-495) from the time of the first RFA in each patient.
  
  
  CONCLUSIONS
  Percutaneous intraluminal RFA combined with biliary stenting is a safe and feasible therapeutic option for unresectable extrahepatic malignant biliary obstruction. Multiple central prospective controlled trials are necessary for the long-term benefits of RFA.
authors: Hepatobiliary Surgery Department, The 309th Hospital of PLA, Beijing, 100091, China, matthewwu1979@126.com.
authors: Tian-Tian
authors: TT
authors: Wu
authors: Hu-Cheng
authors: HC
authors: Li
authors: Wei-Min
authors: WM
authors: Li
authors: Guo-Kun
authors: GK
authors: Ao
authors: Hu
authors: H
authors: Lin
authors: Fang
authors: F
authors: Zheng
authors: Ji-Yong
authors: JY
authors: Song
mesh_terms: D000368:Aged; D001650:Bile Duct Neoplasms / Q000150:complications* / Q000175:diagnosis; D002779:Cholestasis / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011846:Radio Waves; D012189:Retrospective Studies; D016896:Treatment Outcome
references: Lancet. 1992 Dec 19-26;340(8834-8835):1488-92
references: 1281903
references: J Oncol. 2013;2013:910897
references: 23690775
references: Surg Endosc. 2014 Mar;28(3):854-60
references: 24196547
references: Dis Colon Rectum. 2009 Feb;52(2):355-8
references: 19279436
references: Gut. 1995 Apr;36(4):618-21
references: 7537708
references: Biomed Res Int. 2014;2014:642063
references: 25140320
references: N Engl J Med. 1999 Oct 28;341(18):1368-78
references: 10536130
references: Cardiovasc Intervent Radiol. 2013 Jun;36(3):814-9
references: 23232859
references: Arch Surg. 2006 Feb;141(2):181-90
references: 16490897
references: J Vasc Interv Radiol. 1994 Mar-Apr;5(2):279-85
references: 7514463
references: J Invest Surg. 2013 Feb;26(1):6-10
references: 23273142